Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

peramivir

peramivir
  • Restricted Rapivab --> Restricted to ID physician use; limited to patients with influenza who are not a candidate for enteral oseltamivir, cannot take inhaled zanamivir, and no suitable alternatives to intravenous therapy.
  • Restricted Miscellaneous Programs
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Rapivab INJECTION, INTRAVENOUS 200 mg      
Comments:

Formulary status, restricted to ID physician use, use limited to patients with influenza who are not a candidate for enteral oseltamivir (resistance or intolerance), cannot take inhaled zanamivir, and there are no suitable alternatives to intravenous therapy (i.e. cannot do enteral administration due to malabsorption, GI obstruction, etc.)

Automatic renal adjustment per guidelines. See Antimicrobial Dosing Guideline and Renal Adjustment Policy (Adult) for more information.  CrCl calculation policy available here.

Reviewed: 22 September 2015 (Rapivab)

Last updated: Jul. 17, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved